Skip to main content
. Author manuscript; available in PMC: 2025 Aug 25.
Published in final edited form as: J Appl Physiol (1985). 2025 Jul 10;139(2):465–472. doi: 10.1152/japplphysiol.00039.2025

Table 2.

Echocardiographic measures

Control Exercise PhAm ExPhAm
B EOS B EOS B EOS B EOS

EDV(ul) 52.33 ± 7.6 45.18 ± 5.84 53.43 ± 7.4 44.9 ± 3.99 56.28 ± 15.0 49.92 ± 12.97 49.8 ± 6.0 46.5 ± 6.14
ESV(ul) 23.25 ± 5.1 17.7 ± 3.95 22.73 ± 5.1 17.78 ± 2.79 24.23 ± 10.4 16.82 ± 6.25 20.23 ± 3.7 19.83 ± 4.69
SV(ul) 29.08 ± 4.2 27.48 ± 2.88 30.73 ± 3.6 27.14 ± 1.28 32.00 ± 6.7 33.07 ± 7.46 a 29.55 ± 3.5 26.68 ± 3.44
FS (%) 31.43 ± 5.0 37.57 ± 3.25 30.70 ± 7.7 33.88 ± 5.6 32.6 ± 6.7 40.02 ± 8.37 31.4 0± 4.0 30.02 ± 10.94
CO (ml/min) 15.05 ± 2.5 14.58 ± 1.37 14.85 ± 1.9 13.16 ± 0.89 16.82 ± 2.7 17.3 ± 4.1 b 15.15± 1.18 14.1 ± 1.71
GLS (%) −18.26 ± 3.1 −17.42 ± 2.89 −19.56 ± 1.9 −18.1 ± 3.63 −20.68 ± 2.5 −22.73 ± 3.62 c −20.75 ± 2.3 −18.34 ±2.93
EF (%) 55.67 ± 5.7 60.83 ± 4.4 57.83 ± 5.2 60.4 ± 2.88 57.83 ± 8.1 67 ± 6.42 a 59.00 ± 4.3 57.33 ± 6.47
EDLVM 57.33 ± 5.8 69 ± 17.08 83.17 ± 17.9 61.4 ± 12.05 61.33 ± 10.5 61.67 ± 12.14 66.17 ± 7.9 59.17 ± 4.07
ESLVM 54.83 ± 7.1 62.17 ± 13.93 81.17 ± 17.4 57.6 ± 12.26 61.00 ± 11.2 59.33 ± 13.43 65.00 ± 8.7 53.83 ± 6.71
Heart Rate (bpm) 517.7 ± 44.00 531.73 ± 25.43 483.4 ± 32.9 486.08 ± 24.37 530.42 ± 33.9 523.88 ± 47.4 515.88 ± 29.2 527.82 ± 8.39
LV Mass (mg) 63.09 ± 3.52 72.56 ± 4.98 62.97 ± 7.0 69.03 ± 5.45 56.42 ± 11.7 64 ± 12.47 58.70 ± 5.8 63.73 ± 9.41
LV/BM Index (%) 2.88 ± 0.5 2.54 ± 0.26 2.40 ± 0.2 2.49 ± 0.14 2.45 ± 0.5 2.28 ± 0.39 2.44 ±0.1 2.46 ± 0.31

Data are mean ± standard deviatoin. B, Baseline; EOS, End of Study; PhAm, phellodendrun amurense; ExPhAm, exercise with phellodendrun amurense;

a

p≤0.01 compared to ExPhAm,

b

p<0.05 compared to exercise,

c

p<0.05 compared to control.